FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Lincoff

Research Profile

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Devices

Stents

Co-author Network

Publications

TOP 3
Timothy Raymond; Russell Raymond; A Michael Lincoff
Management of the patient with diabetes and coronary artery disease: a contemporary review.
Dharam J Kumbhani; A Michael Lincoff; Brian J Wells; Changhong Yu; Susana Arrigain; Eugene Blackstone; Stephen G Ellis; Marlene Goormastic; Anil Jain; Michael W Kattan
Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromes.
Olcay Aksoy; Christopher T Bajzer; Lillian Batizy; Akin Cam; Leslie Cho; Stephen G Ellis; Irving Franco; A Michael Lincoff; Ravi Nair; Russell Raymond; Mehdi H Shishehbor; Conrad Simpfendorfer; E Murat Tuzcu; Patrick L Whitlow; Shikhar Agarwal; Samir R Kapadia
Percutaneous coronary revascularization in coronary artery disease: lessons from a single center experience.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Lincoff (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Timothy Raymond; Russell Raymond; A Michael Lincoff
Management of the patient with diabetes and coronary artery disease: a contemporary review.
Future cardiology 2013;9(3):387-403.
2013: Dharam J Kumbhani; A Michael Lincoff; Brian J Wells; Changhong Yu; Susana Arrigain; Eugene Blackstone; Stephen G Ellis; Marlene Goormastic; Anil Jain; Michael W Kattan
Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromes.
American journal of cardiovascular disease 2013;3(1):39-52.
2013: Olcay Aksoy; Christopher T Bajzer; Lillian Batizy; Akin Cam; Leslie Cho; Stephen G Ellis; Irving Franco; A Michael Lincoff; Ravi Nair; Russell Raymond; Mehdi H Shishehbor; Conrad Simpfendorfer; E Murat Tuzcu; Patrick L Whitlow; Shikhar Agarwal; Samir R Kapadia
Percutaneous coronary revascularization in coronary artery disease: lessons from a single center experience.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2013;81(1):E1-8.
2012: Christopher H May; A Michael Lincoff
Safety profile and bleeding risk of ticagrelor compared with clopidogrel.
Expert opinion on drug safety 2012;11(6):959-67.
2012: Deepak L Bhatt; Patrice Cacoub; Mark A Creager; John W Eikelboom; Eileen S Emison; Marcus D Flather; Keith A A Fox; Werner Hacke; Kandice Kottke-Marchant; A Michael Lincoff; Koon-Hou Mak; Shamir R Mehta; Gilles Montalescot; Gurunathan Murugesan; Guillaume Paré; Katy L Simonsen; Ph Gabriel Steg; Steven R Steinhubl; Eric J Topol; Peter B Berger; Nihar Bhakta
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study.
European heart journal 2012;33(17):2143-50.
2012: Hani Jneid; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; R Scott Wright; Cynthia D Adams; Jeffrey L Anderson; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; James Patrick Zidar
2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Journal of the American College of Cardiology 2012;60(7):645-81.
2012: Cynthia D Adams; Jeffrey L Anderson; Jeffrey L Anderson; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; Hani Jneid; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; R Scott Wright; James Patrick Zidar
2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
Circulation 2012;126(7):875-910.
2012: Zubin J Eapen; G Michael Felker; Adrian F Hernandez; A Michael Lincoff; Kenneth W Mahaffey; W H Wilson Tang; Matthew T Roe
Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forward.
Circulation. Cardiovascular quality and outcomes 2012;5(4):594-600.
2012: Christopher W Good; A Michael Lincoff; Steven R Steinhubl; Eric J Topol; Danielle M Brennan; Peter B Berger
Is there a clinically significant interaction between calcium channel antagonists and clopidogrel?: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Circulation. Cardiovascular interventions 2012;5(1):77-81.
2012: Per Olav Vandvik; Elie A Akl; Pablo Alonso-Coello; Joel M Gore; David D Gutterman; Gordon H Guyatt; Maarten G Lansberg; A Michael Lincoff; Frank A Sonnenberg; Frederick A Spencer
Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest 2012;141(2 Suppl):e637S-68S.
2012: Christopher H May; A Michael Lincoff
Antiplatelet agents in ischemic heart disease.
Handbook of experimental pharmacology 2012;(210):495-518.
2011: Arun Kalyanasundaram; A Michael Lincoff
Managing adverse effects and drug-drug interactions of antiplatelet agents.
Nature reviews. Cardiology 2011;8(10):592-600.
2011: Jeffrey S Berger; Peter B Berger; Deepak L Bhatt; Keith A Fox; Werner Hacke; Gilles Montalescot; Mingyuan Shao; P Gabriel Steg; Steven R Steinhubl; Eric J Topol; A Michael Lincoff
Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
American heart journal 2011;162(1):98-105.e1.
2011: Shikhar Agarwal; Christopher T Bajzer; Stephen G Ellis; Irving Franco; A Michael Lincoff; Ravi Nair; Russell Raymond; Mehdi H Shishehbor; E Murat Tuzcu; Patrick L Whitlow; Tarique Zaman; Samir R Kapadia
Comparison of outcomes of unprotected left main versus multivessel coronary artery interventions.
The American journal of cardiology 2011;108(1):15-20.
2011: Roxana Mehran; Eugenia Nikolsky; E Magnus Ohman; Helen Parise; Stuart Pocock; Harvey White; Michel Bertrand; Adriano Caixeta; Bimmer E Claessen; Tim Clayton; George D Dangas; Frederick Feit; Alexandra J Lansky; A Michael Lincoff; Steven V Manoukian; Gregg W Stone
Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials.
JACC. Cardiovascular interventions 2011;4(6):654-64.
2011: AMAR KRISHNASWAMY; A Michael Lincoff
Percutaneous coronary intervention for acute coronary syndrome: no difference in 48-h bleeding rate or vascular access-site complications with low- or standard-dose unfractionated heparin in patients initially treated with fondaparinux.
Evidence-based medicine 2011;16(3):72-3.
2011: R Scott Wright; Jeffrey L Anderson; Cynthia D Adams; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; Hani Jneid; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; James Patrick Zidar; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; James Patrick Zidar
2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons.
Journal of the American College of Cardiology 2011;57(19):e215-367.
2011: R Scott Wright; Jeffrey L Anderson; Cynthia D Adams; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; Hani Jneid; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; James Patrick Zidar; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette K Wenger; R Scott Wright
2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
Journal of the American College of Cardiology 2011;57(19):1920-59.
2011: R Scott Wright; Jeffrey L Anderson; Cynthia D Adams; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; Hani Jneid; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; James Patrick Zidar; Alice K Jacobs
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Circulation 2011;123(18):2022-60.
2011: Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Circulation 2011;123(18):e426-579.
2011: Stephen G Ellis; Mehdi H Shishehbor; Samir R Kapadia; A Michael Lincoff; Ravi Nair; Patrick L Whitlow; Christopher T Bajzer; Leslie L Cho; E Murat Tuzcu; Russell Raymond; Patrick Vargo; Rebecca Cunningham; Sandra J Dushman-Ellis
Enhanced prediction of mortality after percutaneous coronary intervention by consideration of general and neurological indicators.
JACC. Cardiovascular interventions 2011;4(4):442-8.
2011: Freek W A Verheugt; Steven R Steinhubl; Martial Hamon; Harald Darius; Philippe Gabriel STEG; Marco Valgimigli; Steven P Marso; Sunil V Rao; Anthony H Gershlick; A Michael Lincoff; Roxana Mehran; Gregg W Stone
Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention.
JACC. Cardiovascular interventions 2011;4(2):191-7.
2011: Adriano Caixeta; Gregg W Stone; Roxana Mehran; Edwin A Lee; Brent T McLaurin; David A Cox; Michel E Bertrand; A Michael Lincoff; Jeffrey W Moses; Harvey D White; E Magnus Ohman; Tullio Palmerini; George Syros; Christos Kittas; Martin Fahy; W Craig Hooper; Alexandra J Lansky; George D Dangas
Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial.
Journal of thrombosis and thrombolysis 2011;31(2):154-64.
2011: Giuseppe Ambrosio; Steven Steinhubl; Paolo Gresele; Isabella Tritto; Cinzia Zuchi; Michel E Bertrand; A Michael Lincoff; Jeffrey W Moses; Erik M Ohman; Harvey D White; Roxana Mehran; Gregg W Stone
Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trial.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2011;18(1):121-8.
2011: AMAR KRISHNASWAMY; A Michael Lincoff; Christopher P Cannon
Bleeding complications of unfractionated heparin.
Expert opinion on drug safety 2011;10(1):77-84.
2010: Inder M Singh; Steven J Filby; Fredy El Sakr; Eiran Z Gorodeski; A Michael Lincoff; Stephen G Ellis; Mehdi H Shishehbor
Drug-eluting stents versus bare-metal stents for treatment of bare-metal in-stent restenosis.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2010;76(2):257-62.
2010: Matthew A Cavender; Stephen J Nicholls; A Michael Lincoff
Strategies for the development of new PPAR agonists in diabetes.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2010;17 Suppl 1():S32-7.
2010: Megan J Dekam; Jeremiah P Depta; A Michael Lincoff
A rare complication of infective endocarditis.
Cleveland Clinic journal of medicine 2010;77(5):296-7.
2010: AMAR KRISHNASWAMY; A Michael Lincoff; Christopher P Cannon
The use and limitations of unfractionated heparin.
Critical pathways in cardiology 2010;9(1):35-40.
2010: Inder M Singh; Steven J Filby; Fredy El Sakr; Eiran Z Gorodeski; A Michael Lincoff; Stephen G Ellis; Mehdi H Shishehbor
Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2010;75(3):338-42.
2010: Stuart J Pocock; Roxana Mehran; Tim C Clayton; Eugenia Nikolsky; Helen Parise; Martin Fahy; Alexandra J Lansky; Michel E Bertrand; A Michael Lincoff; Jeffrey W Moses; Erik Ohman; Harvey D White; Gregg W Stone
Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial.
Circulation 2010;121(1):43-51.
2010: Matthew A Cavender; A Michael Lincoff
Therapeutic potential of aleglitazar, a new dual PPAR-α/γ agonist: implications for cardiovascular disease in patients with diabetes mellitus.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2010;10(4):209-16.
2009: Deepak L Bhatt; A Michael Lincoff; C Michael Gibson; Gregg W Stone; Steven McNulty; Gilles Montalescot; Neal S Kleiman; Shaun G Goodman; Harvey D White; Kenneth W Mahaffey; Charles V Pollack; Steven V Manoukian; Petr Widimsky; Derek P Chew; Fernando Cura; Ivan Manukov; Frantisek Tousek; M Zubair Jafar; Jaspal Arneja; Simona Skerjanec; Robert A Harrington
Intravenous platelet blockade with cangrelor during PCI.
The New England journal of medicine 2009;361(24):2330-41.
2009: Robert A Harrington; Gregg W Stone; Steven McNulty; Harvey D White; A Michael Lincoff; C Michael Gibson; Charles V Pollack; Gilles Montalescot; Kenneth W Mahaffey; Neal S Kleiman; Shaun G Goodman; Maged Amine; Dominick J Angiolillo; Richard C Becker; Derek P Chew; William J French; Franz Leisch; Keyur H Parikh; Simona Skerjanec; Deepak L Bhatt
Platelet inhibition with cangrelor in patients undergoing PCI.
The New England journal of medicine 2009;361(24):2318-29.
2009: Jeffrey S Berger; Deepak L Bhatt; Steven R Steinhubl; Mingyuan Shao; P Gabriel Steg; Gilles Montalescot; Werner Hacke; Keith A Fox; A Michael Lincoff; Eric J Topol; Peter B Berger
Smoking, clopidogrel, and mortality in patients with established cardiovascular disease.
Circulation 2009;120(23):2337-44.
2009: Sunil V Rao; John Eikelboom; Ph Gabriel Steg; A Michael Lincoff; William S Weintraub; Jean-Pierre Bassand; A Koneti Rao; C Michael Gibson; John L Petersen; Roxana Mehran; Steven V Manoukian; Richard Charnigo; Kerry L Lee; Mauro Moscucci; Robert A Harrington
Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group.
American heart journal 2009;158(6):881-886.e1.
2009: Lawrence D Lazar; A Michael Lincoff
Prasugrel for acute coronary syndromes: faster, more potent, but higher bleeding risk.
Cleveland Clinic journal of medicine 2009;76(12):707-14.
2009: AMAR KRISHNASWAMY; A Michael Lincoff; Venu Menon
Magnitude and consequences of missing the acute infarct-related circumflex artery.
American heart journal 2009;158(5):706-12.
2009: Jacob A Doll; Eugenia Nikolsky; Gregg W Stone; Roxana Mehran; A Michael Lincoff; Adriano Caixeta; Brent McLaurin; Ecaterina Cristea; Martin Fahy; Vijaya Kesanakurthy; Alexandra J Lansky
Outcomes of patients with coronary artery perforation complicating percutaneous coronary intervention and correlations with the type of adjunctive antithrombotic therapy: pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials.
Journal of interventional cardiology 2009;22(5):453-9.
2009: Eugenia Nikolsky; Gregg W Stone; Ajay J Kirtane; George Dangas; Alexandra J Lansky; Brent McLaurin; A Michael Lincoff; Frederick Feit; Jeffrey W Moses; Martin Fahy; Steven V Manoukian; Harvey D White; Erik Ohman; Michel E Bertrand; David A Cox; Roxana Mehran
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
Journal of the American College of Cardiology 2009;54(14):1293-302.
2009: Arman T Askari; Mehdi H Shishehbor; Matthew A Kaminski; Michael J Riley; Amy Hsu; A Michael Lincoff
The association between early ventricular arrhythmias, renin-angiotensin-aldosterone system antagonism, and mortality in patients with ST-segment-elevation myocardial infarction: Insights from Global Use of Strategies to Open coronary arteries (GUSTO) V.
American heart journal 2009;158(2):238-43.
2009: Abhiram Prasad; Bernard J Gersh; Michel E Bertrand; A Michael Lincoff; Jeffrey W Moses; Erik Ohman; Harvey D White; Stuart J Pocock; Brent T McLaurin; David A Cox; Alexandra J Lansky; Roxana Mehran; Gregg W Stone
Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
Journal of the American College of Cardiology 2009;54(5):477-86.
2009: Robert R Henry; A Michael Lincoff; Sunder Mudaliar; Michael Rabbia; Cathy Chognot; Matthias Herz
Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study.
Lancet 2009;374(9684):126-35.
2009: Adnan K Chhatriwalla; Akin Cam; Samuel Unzek; Deepak L Bhatt; Russell E Raymond; A Michael Lincoff; Patrick L Whitlow; Stephen G Ellis; E Murat Tuzcu; Samir R Kapadia
Drug-eluting stent fracture and acute coronary syndrome.
Cardiovascular revascularization medicine : including molecular interventions 2009;10(3):166-71.
2009: Ramin Ebrahimi; Cornelius Dyke; Roxana Mehran; Steven V Manoukian; Frederick Feit; David A Cox; Bernard J Gersh; Erik Ohman; Harvey D White; Jeffrey W Moses; James H Ware; A Michael Lincoff; Gregg W Stone
Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
Journal of the American College of Cardiology 2009;53(21):1965-72.
2009: Mehdi H Shishehbor; Steven J Filby; Adnan K Chhatriwalla; Ryan D Christofferson; Anil Jain; Samir R Kapadia; A Michael Lincoff; Deepak L Bhatt; Stephen G Ellis
Impact of drug-eluting versus bare-metal stents on mortality in patients with anemia.
JACC. Cardiovascular interventions 2009;2(4):329-36.
2009: Matthew C Becker; Thomas H Wang; Lisa Wisniewski; Kathy Wolski; Peter Libby; Thomas F Lüscher; Jeffrey S Borer; Alice M Mascette; M Elaine Husni; Daniel H Solomon; David Y Graham; Neville D Yeomans; Henry Krum; Frank Ruschitzka; A Michael Lincoff; Steven E Nissen
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis.
American heart journal 2009;157(4):606-12.
2009: Jiro Aoki; Alexandra J Lansky; Roxana Mehran; Jeffery Moses; Michel E Bertrand; Brent T McLaurin; David A Cox; A Michael Lincoff; Erik Ohman; Harvey D White; Helen Parise; Martin B Leon; Gregg W Stone
Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial.
Circulation 2009;119(5):687-98.
2008: A Michael Lincoff; Steven R Steinhubl; Steven V Manoukian; Derek Chew; Charles V Pollack; Frederick Feit; James H Ware; Michel E Bertrand; Erik Ohman; Walter Desmet; David A Cox; Roxana Mehran; Gregg W Stone
Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
JACC. Cardiovascular interventions 2008;1(6):639-48.
2008: Duane S Pinto; Gregg W Stone; Chunxue Shi; Elizabeth S Dunn; Matthew R Reynolds; Meghan York; Joshua Walczak; Ronna H Berezin; Roxana Mehran; Brent T McLaurin; David A Cox; Erik Ohman; A Michael Lincoff; David J Cohen
Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes.
Journal of the American College of Cardiology 2008;52(22):1758-68.
2008: Herbert D Aronow; A Michael Lincoff; Martin J Quinn; A Thomas McRae; Hitinder S Gurm; Penny L Houghtaling; Christopher B Granger; Robert A Harrington; Franz Van de Werf; Eric J Topol; Michael Lauer
Relation between previous lipid-lowering therapy and infarct size (creatine kinase-MB level) in patients presenting with acute myocardial infarction.
The American journal of cardiology 2008;102(9):1119-24.
2008: Harvey D White; Erik Ohman; A Michael Lincoff; Michel E Bertrand; Antonio Colombo; Brent T McLaurin; David A Cox; Stuart J Pocock; James A Ware; Steven V Manoukian; Alexandra J Lansky; Roxana Mehran; Jeffrey W Moses; Gregg W Stone
Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
Journal of the American College of Cardiology 2008;52(10):807-14.
2008: William R Hiatt; A Michael Lincoff; Robert A Harrington
Acute pharmacological conversion of atrial fibrillation to sinus rhythm: is short-term symptomatic therapy worth it? A report from the December 2007 Meeting of the Cardiovascular and Renal Drugs Advisory Committee of the Food and Drug Administration.
Circulation 2008;117(22):2956-7.
2008: Robert A Harrington; Richard C Becker; Christopher P Cannon; David Gutterman; A Michael Lincoff; Jeffrey J Popma; Gabriel Steg; Gordon H Guyatt; Shaun G Goodman
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Chest 2008;133(6 Suppl):670S-707S.
2008: Harvey D White; Derek P Chew; James W Hoekstra; Chadwick D Miller; Charles V Pollack; Frederick Feit; A Michael Lincoff; Michel Bertrand; Stuart Pocock; James Ware; Erik Ohman; Roxana Mehran; Gregg W Stone
Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
Journal of the American College of Cardiology 2008;51(18):1734-41.
2008: Steven E Nissen; Stephen J Nicholls; Kathy Wolski; Josep Rodés-Cabau; Christopher P Cannon; John E Deanfield; Jean-Pierre Després; John J P Kastelein; Steven R Steinhubl; Samir Kapadia; Muhammad Yasin; Witold Ruzyllo; Christophe Gaudin; Bernard Job; Bo Hu; Deepak L Bhatt; A Michael Lincoff; E Murat Tuzcu
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial.
JAMA : the journal of the American Medical Association 2008;299(13):1547-60.
2008: Steven E Nissen; Stephen J Nicholls; Kathy Wolski; Richard Nesto; Stuart Kupfer; Alfonso Perez; Horacio Jure; Robert De Larochellière; Cezar Staniloae; Kreton Mavromatis; Jacqueline Saw; Bo Hu; A Michael Lincoff; E Murat Tuzcu
Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.
JAMA : the journal of the American Medical Association 2008;299(13):1561-73.
2008: Surabhi Madhwal; A Michael Lincoff; David D K Rolston
Should patients on long-term warfarin take aspirin for heart disease?
Cleveland Clinic journal of medicine 2008;75(3):206-8.
2008: Gian M Novaro; Craig R Asher; Deepak L Bhatt; David J Moliterno; Robert A Harrington; A Michael Lincoff; L Kristin Newby; James E Tcheng; Amy P Hsu; Sergio L Pinski
Meta-analysis comparing reported frequency of atrial fibrillation after acute coronary syndromes in Asians versus whites.
The American journal of cardiology 2008;101(4):506-9.
2008: Kellan E Ashley; A Michael Lincoff
Pharmacologic inhibition of platelet function: correlation between in vitro tests of platelet function and clinical outcomes.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2008;8(5):283-95.
2007: Gregg W Stone; James H Ware; Michel E Bertrand; A Michael Lincoff; Jeffrey W Moses; Erik Ohman; Harvey D White; Frederick Feit; Antonio Colombo; Brent T McLaurin; David A Cox; Steven V Manoukian; Martin Fahy; Tim C Clayton; Roxana Mehran; Stuart J Pocock
Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.
JAMA : the journal of the American Medical Association 2007;298(21):2497-506.
2007: Frederick Feit; Michele D Voeltz; Michael J Attubato; A Michael Lincoff; Derek P Chew; John A Bittl; Eric J Topol; Steven V Manoukian
Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial.
The American journal of cardiology 2007;100(9):1364-9.
2007: Harmony R Reynolds; Michael E Farkouh; A Michael Lincoff; Amy Hsu; Eva Swahn; Zygmunt P Sadowski; Jennifer A White; Eric J Topol; Judith S Hochman
Impact of female sex on death and bleeding after fibrinolytic treatment of myocardial infarction in GUSTO V.
Archives of internal medicine 2007;167(19):2054-60.
2007: A Michael Lincoff; Kathy Wolski; Stephen J Nicholls; Steven E Nissen
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.
JAMA : the journal of the American Medical Association 2007;298(10):1180-8.
2007: Cornelius M Dyke; Gabriel S Aldea; Andreas Koster; Nicholas Smedira; Edwin Avery; Solomon Aronson; Bruce D Spiess; A Michael Lincoff
Off-pump coronary artery bypass with bivalirudin for patients with heparin-induced thrombocytopenia or antiplatelet factor four/heparin antibodies.
The Annals of thoracic surgery 2007;84(3):836-9.
2007: Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette K Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Jonathan L Halperin; Sharon Ann Hunt; Harlan Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.
Journal of the American College of Cardiology 2007;50(7):e1-e157.
2007: Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette K Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Jonathan L Halperin; Sharon Ann Hunt; Harlan Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.
Circulation 2007;116(7):e148-304.
2007: Eugenia Nikolsky; Roxana Mehran; George Dangas; Martin Fahy; Yingbo Na; Stuart J Pocock; A Michael Lincoff; Gregg W Stone
Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach.
European heart journal 2007;28(16):1936-45.
2007: John M Galla; A Michael Lincoff
The role of clopidogrel in the management of ischemic heart disease.
Current opinion in cardiology 2007;22(4):273-9.
2007: C Michael Gibson; Yuli Ten; Sabina A Murphy; Lauren N Ciaglo; Matthew C Southard; A Michael Lincoff; Ron Waksman
Association of prerandomization anticoagulant switching with bleeding in the setting of percutaneous coronary intervention (A REPLACE-2 analysis).
The American journal of cardiology 2007;99(12):1687-90.
2007: Michele D Voeltz; Amar D Patel; Frederick Feit; Reza Fazel; A Michael Lincoff; Steven V Manoukian
Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention.
The American journal of cardiology 2007;99(11):1513-7.
2007: Hitinder S Gurm; Vivek Rajagopal; Deepak L Bhatt; Stephen G Ellis; A Michael Lincoff
The safety of a bivalirudin-based approach in patients undergoing rotational atherectomy.
The Journal of invasive cardiology 2007;19(5):225-8.
2007: Steven V Manoukian; Frederick Feit; Roxana Mehran; Michele D Voeltz; Ramin Ebrahimi; Martial Hamon; George Dangas; A Michael Lincoff; Harvey D White; Jeffrey W Moses; Spencer B King; Erik Ohman; Gregg W Stone
Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial.
Journal of the American College of Cardiology 2007;49(12):1362-8.
2007: Gregg W Stone; Harvey D White; Erik Ohman; Michel E Bertrand; A Michael Lincoff; Brent T McLaurin; David A Cox; Stuart J Pocock; James H Ware; Frederick Feit; Antonio Colombo; Steven V Manoukian; Alexandra J Lansky; Roxana Mehran; Jeffrey W Moses
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.
Lancet 2007;369(9565):907-19.
2007: John McB Hodgson; Gregg W Stone; A Michael Lincoff; Lloyd Klein; Howard Walpole; Randy K Bottner; Bonnie H Weiner; Martin B Leon; Ted Feldman; Joseph Babb; Gregory J Dehmer
Late stent thrombosis: considerations and practical advice for the use of drug-eluting stents: a report from the Society for Cardiovascular Angiography and Interventions Drug-eluting Stent Task Force.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2007;69(3):327-33.
2007: Gregg W Stone; Michel E Bertrand; Jeffrey W Moses; Erik Ohman; A Michael Lincoff; James H Ware; Stuart J Pocock; Brent T McLaurin; David A Cox; M Zubair Jafar; Harish Chandna; Franz Hartmann; Franz Leisch; Ruth H Strasser; Martin Desaga; Thomas D Stuckey; Richard B Zelman; Ira H Lieber; David J Cohen; Roxana Mehran; Harvey D White
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.
JAMA : the journal of the American Medical Association 2007;297(6):591-602.
2007: Andreas Koster; Cornelius M Dyke; Gabriel S Aldea; Nicholas G Smedira; Harry L McCarthy; Solomon Aronson; Roland Hetzer; Edwin Avery; Bruce Spiess; A Michael Lincoff
Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial.
The Annals of thoracic surgery 2007;83(2):572-7.
2006: Gregg W Stone; Brent T McLaurin; David A Cox; Michel E Bertrand; A Michael Lincoff; Jeffrey W Moses; Harvey D White; Stuart J Pocock; James H Ware; Frederick Feit; Antonio Colombo; Philip E Aylward; Angel R Cequier; Harald Darius; Walter Desmet; Ramin Ebrahimi; Martial Hamon; Lars H Rasmussen; Hans-Jürgen Rupprecht; James Hoekstra; Roxana Mehran; Erik Ohman
Bivalirudin for patients with acute coronary syndromes.
The New England journal of medicine 2006;355(21):2203-16.
2006: Jacqueline Saw; Deepak L Bhatt; David J Moliterno; Sorin J Brener; Steven R Steinhubl; A Michael Lincoff; James E Tcheng; Robert A Harrington; Maarten L Simoons; TingFei Hu; Mobeen A Sheikh; Dean J Kereiakes; Eric J Topol
The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials.
Journal of the American College of Cardiology 2006;48(8):1567-72.
2006: Juhana Karha; Hitinder S Gurm; Vivek Rajagopal; Robert B Fathi; Anthony A Bavry; Sorin J Brener; A Michael Lincoff; Stephen G Ellis; Deepak L Bhatt
Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes.
The American journal of cardiology 2006;98(7):906-10.
2006: Anjli Maroo; Peter A Rasmussen; Thomas J Masaryk; Stephen G Ellis; A Michael Lincoff; Samir Kapadia
Stent-assisted detachable coil embolization of pseudoaneurysms in the coronary circulation.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2006;68(3):409-15.
2006: John Kao; A Michael Lincoff; Eric J Topol; Antonio Madrid; Matthew J Price; Neil Sawhney; Paul S Teirstein
Direct thrombin inhibition appears to be a safe and effective anticoagulant for percutaneous bypass graft interventions.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2006;68(3):352-6.
2006: Jose E Exaire; Samuel M Butman; Ramin Ebrahimi; Neal S Kleiman; Robert A Harrington; Marc J Schweiger; John A Bittl; Kathy Wolski; Eric J Topol; A Michael Lincoff
Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial.
American heart journal 2006;152(1):157-63.
2006: Vivek Rajagopal; A Michael Lincoff; David J Cohen; Hitinder S Gurm; Tingfei Hu; Walter Desmet; Neal S Kleiman; John A Bittl; Frederick Feit; Eric J Topol
Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial.
American heart journal 2006;152(1):149-54.
2006: Taral N Patel; Mark Kreindel; A Michael Lincoff
Use of ticlopidine and cilostazol after intracoronary drug-eluting stent placement in a patient with previous clopidogrel-induced thrombotic thrombocytopenic purpura: a case report.
The Journal of invasive cardiology 2006;18(7):E211-3.
2006: Jason O Robertson; A Michael Lincoff; Kathy Wolski; Eric J Topol
Planned versus provisional use of glycoprotein IIb/IIIa inhibitors in smokers undergoing percutaneous coronary intervention.
The American journal of cardiology 2006;97(12):1679-84.
2006: A Michael Lincoff
How do unfractionated and low-molecular-weight heparin compare after ST-segment elevation MI?
Nature clinical practice. Cardiovascular medicine 2006;3(6):300-1.
2006: James C Blankenship; Thomas A Haldis; Frederick Feit; Tingfei Hu; Neal S Kleiman; Eric J Topol; A Michael Lincoff
Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy).
The American journal of cardiology 2006;97(11):1591-6.
2006: MATTHEWS CHACKO; A Michael Lincoff; Kathy Wolski; David J Cohen; John A Bittl; Alexandra J Lansky; Yoshihiro Tsuchiya; Amadeo Betriu; Michael H Yen; Derek P Chew; Leslie Cho; Eric J Topol
Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial.
American heart journal 2006;151(5):1032.e1-7.
2006: Padma Kaul; Wei-Ching Chang; A Michael Lincoff; Philip E Aylward; Amadeo Betriu; Christoph Bode; Robert M Califf; Erik Ohman; Victor Guetta; Philippe Gabriel STEG; Frans Van de Werf; Paul W Armstrong
Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trial.
European heart journal 2006;27(10):1198-206.
2006: Anthony A Bavry; A Michael Lincoff
Is clopidogrel cardiovascular medicine's double-edged sword?
Circulation 2006;113(13):1638-40.
2006: Kai Wang; Zhongmin Zhou; Ming Zhang; Liming Fan; Farhad Forudi; Xiaorong Zhou; Wu Qu; A Michael Lincoff; Ann Marie Schmidt; Eric J Topol; Marc S Penn
Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model.
The Journal of pharmacology and experimental therapeutics 2006;317(1):37-43.
2006: Nicholas G Smedira; Cornelius M Dyke; Andreas Koster; Michael J Jurmann; Devinder S Bhatia; Tingfei Hu; Harry L McCarthy; A Michael Lincoff; Bruce D Spiess; Solomon Aronson
Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study.
The Journal of thoracic and cardiovascular surgery 2006;131(3):686-92.
2006: Cornelius M Dyke; Nicholas G Smedira; Andreas Koster; Solomon Aronson; Harry L McCarthy; Ronald Kirshner; A Michael Lincoff; Bruce D Spiess
A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
The Journal of thoracic and cardiovascular surgery 2006;131(3):533-9.
2006: Sunil V Rao; Kristi O'Grady; Karen S Pieper; Christopher B Granger; L Kristin Newby; Kenneth W Mahaffey; David J Moliterno; A Michael Lincoff; Paul W Armstrong; Frans Van de Werf; Robert M Califf; Robert A Harrington
A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes.
Journal of the American College of Cardiology 2006;47(4):809-16.
2005: Ramin Ebrahimi; A Michael Lincoff; John A Bittl; Derek Chew; Kathy Wolski; Nitin Wadhan; Edward J Toggart; Eric J Topol
Bivalirudin vs heparin in percutaneous coronary intervention: a pooled analysis.
Journal of cardiovascular pharmacology and therapeutics 2005;10(4):209-16.
2005: Glenn N Levine; A Michael Lincoff; James J Ferguson; Kenneth W Mahaffey; Shaun G Goodman; Christopher P Cannon; Pierre Theroux; Keith A A Fox
Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decade.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2005;66(2):149-57.
2005: Kai Wang; Xiaorong Zhou; Zhongmin Zhou; Niladri Mal; Liming Fan; Ming Zhang; A Michael Lincoff; Edward F Plow; Eric J Topol; Marc S Penn
Platelet, not endothelial, P-selectin is required for neointimal formation after vascular injury.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(8):1584-9.
2005: Brahmajee K Nallamothu; Eric R Bates; Judith S Hochman; Christopher B Granger; Victor Guetta; Robert G Wilcox; Harvey D White; Paul W Armstrong; Stefano Savonitto; Gang Jia; A Michael Lincoff; Eric J Topol
Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial.
European heart journal 2005;26(15):1506-12.
2005: Sorin J Brener; A Michael Lincoff; Eric R Bates; Gang Jia; Paul W Armstrong; Victor Guetta; Judith S Hochman; Stefano Savonitto; Robert G Wilcox; Harvey D White; Eric J Topol
The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial.
American heart journal 2005;150(1):89-93.
2005: Michael S Chen; A Michael Lincoff
Direct thrombin inhibitors.
Current cardiology reports 2005;7(4):255-9.
2005: Hitinder S Gurm; Ian J Sarembock; Dean J Kereiakes; John J Young; Robert A Harrington; Neal S Kleiman; Frederick Feit; Kathy Wolski; John A Bittl; Robert Wilcox; Eric J Topol; A Michael Lincoff
Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial.
Journal of the American College of Cardiology 2005;45(12):1932-8.
2005: Kenneth W Mahaffey; Matthew T Roe; Rakhi Kilaru; John K French; John H Alexander; Lisa G Berdan; Frans Van de Werf; Maarten L Simoons; W Douglas Weaver; Harvey D White; A Michael Lincoff; Neal S Kleiman; Eric J Topol; Robert A Harrington
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes.
The American journal of cardiology 2005;95(12):1404-8.
2005: Andreas Koster; Ruhi Yeter; Semih Buz; Hermann Kuppe; Roland Hetzer; A Michael Lincoff; Cornelius M Dyke; Nicholas G Smedira; Bruce Spiess
Assessment of hemostatic activation during cardiopulmonary bypass for coronary artery bypass grafting with bivalirudin: results of a pilot study.
The Journal of thoracic and cardiovascular surgery 2005;129(6):1391-4.
2005: Hitinder S Gurm; Vivek Rajagopal; Robert B Fathi; Deepak Vivekanathan; Jay S Yadav; Deepak L Bhatt; Stephen G Ellis; A Michael Lincoff; Eric J Topol
Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical center.
The American journal of cardiology 2005;95(6):716-21.
2005: John H Alexander; Hongqiu Yang; Richard C Becker; K Kodama; S Goodman; Christopher K Dyke; Neal S Kleiman; Judith S Hochman; P B Berger; E A Cohen; A Michael Lincoff; J R Burton; Edwin G Bovill; C Kawai; Paul W Armstrong; Robert A Harrington
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial.
Journal of thrombosis and haemostasis : JTH 2005;3(3):439-47.
2005: Abdallah G Rebeiz; Per Johanson; Cynthia L Green; Suzanne W Crater; Matthew T Roe; Anatoly Langer; Robert P Giugliano; A Michael Lincoff; L Kristin Newby; Robert A Harrington; Eric J Topol; Robert M Califf; Galen S Wagner; Mitchell W Krucoff
Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials).
The American journal of cardiology 2005;95(5):611-4.
2005: Derek P Chew; A Michael Lincoff; Hitinder S Gurm; Kathy Wolski; David J Cohen; Tim Henry; Frederick Feit; Eric J Topol
Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial).
The American journal of cardiology 2005;95(5):581-5.
2005: Marino Labinaz; Jasmine Mathias; Karen S Pieper; Christopher B Granger; A Michael Lincoff; David J Moliterno; Frans Van de Werf; R John Simes; Harvey D White; Maarten L Simoons; Robert M Califf; Eric J Topol; Paul W Armstrong; Robert A Harrington
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials.
European heart journal 2005;26(2):128-36.
2005: Kai Wang; Khaldoun Tarakji; Zhongmin Zhou; Ming Zhang; Farhad Forudi; Xiaorong Zhou; Alane T Koki; Mark E Smith; Bradley T Keller; Eric J Topol; A Michael Lincoff; Marc S Penn
Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model.
Journal of cardiovascular pharmacology 2005;45(1):61-7.
2004: W H Wilson Tang; A Michael Lincoff
Diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa blockade: the triad revisited.
Circulation 2004;110(24):3618-20.
2004: John H Chiu; Deepak L Bhatt; Khaled M Ziada; Derek P Chew; Patrick L Whitlow; A Michael Lincoff; Stephen G Ellis; Eric J Topol
Impact of female sex on outcome after percutaneous coronary intervention.
American heart journal 2004;148(6):998-1002.
2004: David J Cohen; A Michael Lincoff; Tara A Lavelle; Huei-Ling Chen; Ameet Bakhai; Ronna H Berezin; Daniel Jackman; Ian J Sarembock; Eric J Topol
Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial.
Journal of the American College of Cardiology 2004;44(9):1792-800.
2004: Gregg W Stone; Michel Bertrand; Antonio Colombo; George Dangas; Michael E Farkouh; Frederick Feit; Alexandra J Lansky; A Michael Lincoff; Roxana Mehran; Jeffrey W Moses; Magnus Ohman; Harvey D White
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale.
American heart journal 2004;148(5):764-75.
2004: Fernando A Cura; Marco Roffi; Narcis Pasca; Kathy Wolski; A Michael Lincoff; Eric J Topol; Michael Lauer
ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy).
The American journal of cardiology 2004;94(7):859-63.
2004: Stephen G Ellis; Christopher T Bajzer; Deepak L Bhatt; Sorin J Brener; Patrick L Whitlow; A Michael Lincoff; David J Moliterno; Russell E Raymond; E Murat Tuzcu; Irving Franco; Sandra Dushman-Ellis; Katherine J Lander; Jakob P Schneider; Eric J Topol
Real-world bare metal stenting: identification of patients at low or very low risk of 9-month coronary revascularization.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2004;63(2):135-40.
2004: Jacqueline Saw; A Michael Lincoff; Walter Desmet; Amadeo Betriu; Wolfgang Rutsch; Robert G Wilcox; Neal S Kleiman; Kathy Wolski; Eric J Topol
Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy.
Journal of the American College of Cardiology 2004;44(6):1194-9.
2004: Sorin J Brener; David J Moliterno; A Michael Lincoff; Steven R Steinhubl; Kathy Wolski; Eric J Topol
Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention.
Circulation 2004;110(8):994-8.
2004: A Michael Lincoff; Neal S Kleiman; Dean J Kereiakes; Frederick Feit; John A Bittl; J Daniel Jackman; Ian J Sarembock; David J Cohen; Douglas Spriggs; Ramin Ebrahimi; Gadi Keren; Jeffrey Carr; Eric A Cohen; Amadeo Betriu; Walter Desmet; Wolfgang Rutsch; Robert G Wilcox; Pim J de Feyter; Alec Vahanian; Eric J Topol
Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial.
JAMA : the journal of the American Medical Association 2004;292(6):696-703.
2004: John L Petersen; Kenneth W Mahaffey; Richard C Becker; Shaun G Goodman; Neal S Kleiman; A J Marian; Gregg W Stone; Alexandra J Lansky; A Michael Lincoff; Stanley L Hazen; Christopher C. Nessel; Luis Toro-Figueroa; Lynn Tate; Craig J Reist; Marc Cohen; Robert M Califf; James J Ferguson
Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY Library.
American heart journal 2004;148(2):269-76.
2004: Vivek Rajagopal; Hitinder S Gurm; Deepak L Bhatt; A Michael Lincoff; James E Tcheng; Dean J Kereiakes; Neal S Kleiman; Gang Jia; Eric J Topol
Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortality.
The American journal of cardiology 2004;94(2):190-2.
2004: Eric J Topol; Deepak L Bhatt; Charles Simonton; Steven Steinhubl; A Michael Lincoff
Here and now--state of the art: optimal antithrombotic strategy for percutaneous coronary intervention-panel discussion.
The Journal of invasive cardiology 2004;16(7 Suppl):30S-31S.
2004: A Michael Lincoff
Glycoprotein IIb/IIIa inhibitors.
The Journal of invasive cardiology 2004;16(7 Suppl):11S-16S.
2004: Hitinder S Gurm; A Michael Lincoff; Neal S Kleiman; Dean J Kereiakes; James E Tcheng; Herbert D Aronow; Arman T Askari; Danielle M Brennan; Eric J Topol
Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions.
The American journal of cardiology 2004;94(1):30-4.
2004: Anjli Maroo; A Michael Lincoff
Bivalirudin in PCI: an overview of the REPLACE-2 trial.
Seminars in thrombosis and hemostasis 2004;30(3):329-36.
2004: A Michael Lincoff; John A Bittl; Neal S Kleiman; Ian J Sarembock; J Daniel Jackman; Sameer Mehta; Mark A Tannenbaum; Alan L Niederman; William B Bachinsky; J Tift-Mann; H Graham Parker; Dean J Kereiakes; Robert A Harrington; Frederick Feit; Elizabeth S Maierson; Derek P Chew; Eric J Topol
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).
The American journal of cardiology 2004;93(9):1092-6.
2004: Jean-Pierre Dery; Gregory A Braden; A Michael Lincoff; Dean J Kereiakes; Kevin Browne; Thomas Little; Barry S George; David C Sane; Douglas B Cines; Mark B Effron; Mary Ann Mascelli; Mary Ann Langrall; Lakshmi V Damaraju; Elliot S Barnathan; James E Tcheng
Final results of the ReoPro readministration registry.
The American journal of cardiology 2004;93(8):979-84.
2004: A Michael Lincoff
Coupling drug and catheter therapy for myocardial infarction.
JAMA : the journal of the American Medical Association 2004;291(8):1000-2.
2004: Hitinder S Gurm; A Michael Lincoff; David S Lee; W H Wilson Tang; Gang Jia; Joan E Booth; Robert M Califf; Erik Ohman; Frans Van de Werf; Paul W Armstrong; Victor Guetta; Robert Wilcox; Eric J Topol
Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial.
Journal of the American College of Cardiology 2004;43(4):542-8.
2004: John H Alexander; Christopher K Dyke; Hongqiu Yang; Richard C Becker; Vic Hasselblad; Linda A Zillman; Neal S Kleiman; Judith S Hochman; P B Berger; E A Cohen; A Michael Lincoff; Henock Saint-Jacques; Stanley Chetcuti; J R Burton; J M Buergler; F P Spence; Yoshimasa Shimoto; Thomas L Robertson; Satoshi Kunitada; Edwin G Bovill; Paul W Armstrong; Robert A Harrington
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot.
Journal of thrombosis and haemostasis : JTH 2004;2(2):234-41.
2004: Matthew T Roe; Kenneth W Mahaffey; Rakhi Kilaru; John H Alexander; K Martijn Akkerhuis; Maarten L Simoons; Robert A Harrington; Barbara E Tardiff; Christopher B Granger; Erik Ohman; David J Moliterno; A Michael Lincoff; Paul W Armstrong; Frans Van de Werf; Robert M Califf; Eric J Topol
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
European heart journal 2004;25(4):313-21.
2004: Andreas Koster; Bruce Spiess; Derek P Chew; Thomas Krabatsch; Luc Tambeur; Abelardo DeAnda Jr.; Roland Hetzer; Hermann Kuppe; Nicholas G Smedira; A Michael Lincoff
Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting.
The American journal of cardiology 2004;93(3):356-9.
2004: Jose E Exaire; A Michael Lincoff
Should glycoprotein IIb/IIIa inhibitors be used during all percutaneous coronary interventions? Yes.
Journal of thrombosis and haemostasis : JTH 2004;2(1):7-9.
2003: Debabrata Mukherjee; Amy Hsu; David J Moliterno; A Michael Lincoff; Marlene Goormastic; Eric J Topol
Risk factors for premature coronary artery disease and determinants of adverse outcomes after revascularization in patients < or =40 years old.
The American journal of cardiology 2003;92(12):1465-7.
2003: John H Alexander; Robert A Harrington; Manjushri Bhapkar; Kenneth W Mahaffey; A Michael Lincoff; Erik Ohman; Peter Klootwijk; Olle Pahlm; Bo Henden; Jaap Deckers; Maarten L Simoons; Robert M Califf; Galen S Wagner
Prognostic importance of new small Q waves following non-ST-elevation acute coronary syndromes.
The American journal of medicine 2003;115(8):613-9.
2003: Herbert D Aronow; Gian M Novaro; Michael Lauer; Danielle M Brennan; A Michael Lincoff; Eric J Topol; Dean J Kereiakes; Steven E Nissen
In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis.
Archives of internal medicine 2003;163(21):2576-82.
2003: Umesh N Khot; Gang Jia; David J Moliterno; A Michael Lincoff; Monica B Khot; Robert A Harrington; Eric J Topol
Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification.
JAMA : the journal of the American Medical Association 2003;290(16):2174-81.
2003: Derek P Chew; Deepak L Bhatt; William Kimball; Timothy D Henry; Peter Berger; Peter A McCullough; Frederick Feit; John A Bittl; A Michael Lincoff
Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials.
The American journal of cardiology 2003;92(8):919-23.
2003: A Michael Lincoff
Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?
American heart journal 2003;146(4 Suppl):S23-30.
2003: Hitinder S Gurm; D L Bhatt; A Michael Lincoff; J E Tcheng; D J Kereiakes; N S Kleiman; G Jia; Eric J Topol
Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials.
Heart (British Cardiac Society) 2003;89(10):1200-4.
2003: Umesh N Khot; Monica B Khot; Christopher T Bajzer; Shelly K Sapp; Erik Ohman; Sorin J Brener; Stephen G Ellis; A Michael Lincoff; Eric J Topol
Prevalence of conventional risk factors in patients with coronary heart disease.
JAMA : the journal of the American Medical Association 2003;290(7):898-904.
2003: Keith Ellis; James E Tcheng; Shelly K Sapp; Eric J Topol; A Michael Lincoff
Mortality benefit of beta blockade in patients with acute coronary syndromes undergoing coronary intervention: pooled results from the Epic, Epilog, Epistent, Capture and Rapport Trials.
Journal of interventional cardiology 2003;16(4):299-305.
2003: Deepak L Bhatt; Derek P Chew; A Michael Lincoff; Maarten L Simoons; Robert A Harrington; Steve R Ommen; Gang Jia; Eric J Topol
Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes.
The American journal of cardiology 2003;92(2):136-40.
2003: Sunil V Rao; Padma Kaul; L Kristin Newby; A Michael Lincoff; Judith S Hochman; Robert A Harrington; Daniel B Mark; eric peterson
Poverty, process of care, and outcome in acute coronary syndromes.
Journal of the American College of Cardiology 2003;41(11):1948-54.
2003: Zhongmin Zhou; Kai Wang; Marc S Penn; Steven P Marso; Michael A Lauer; Farhad Forudi; Xiaorong Zhou; Wu Qu; Yan Lu; David M Stern; Ann Marie Schmidt; A Michael Lincoff; Eric J Topol
Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury.
Circulation 2003;107(17):2238-43.
2003: Kai Wang; Paul D Kessler; Zhongmin Zhou; Marc S Penn; Farhad Forudi; Xiaorong Zhou; Khaldoun Tarakji; Melina R Kibbe; Imre Kovesdi; Douglas E Brough; Eric J Topol; A Michael Lincoff
Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented model.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;7(5 Pt 1):597-603.
2003: Leslie Cho; Kandice Kottke-Marchant; A Michael Lincoff; Marco Roffi; Joel P Reginelli; Theresa Kaldus; David J Moliterno
Correlation of point-of-care ecarin clotting time versus activated clotting time with bivalirudin concentrations.
The American journal of cardiology 2003;91(9):1110-3.
2003: James E Tcheng; Mina Madan; J Conor O'Shea; Eric A Cohen; Christopher E Buller; A Michael Lincoff; Jeffrey J Popma; Paul S Teirstein; Michael M Kitt; Todd J Lorenz; Sally Greenberg; NORMAN FOST; Robert M Califf
Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention.
Journal of interventional cardiology 2003;16(2):97-105.
2003: A Michael Lincoff
Important triad in cardiovascular medicine: diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa receptor blockade.
Circulation 2003;107(11):1556-9.
2003: Leslie Cho; Derek P Chew; David J Moliterno; Marco Roffi; Stephen G Ellis; Irving Franco; Christopher T Bajzer; Deepak L Bhatt; Khosrow Dorosti; Conrad Simpfendorder; Murat Tuzcu; Jay S Yadav; Sorin J Brener; Russell E Raymond; Patrick L Whitlow; Eric J Topol; A Michael Lincoff
Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition.
The American journal of cardiology 2003;91(6):742-3.
2003: A Michael Lincoff; John A Bittl; Robert A Harrington; Frederick Feit; Neal S Kleiman; J Daniel Jackman; Ian J Sarembock; David J Cohen; Douglas Spriggs; Ramin Ebrahimi; Gadi Keren; Jeffrey Carr; Eric A Cohen; Amadeo Betriu; Walter Desmet; Dean J Kereiakes; Wolfgang Rutsch; Robert G Wilcox; Pim J de Feyter; Alec Vahanian; Eric J Topol
Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.
JAMA : the journal of the American Medical Association 2003;289(7):853-63.
2003: Kai Wang; Xiaorong Zhou; Zhongmin Zhou; Khaldoun Tarakji; Marcelo Carneiro; Marc S Penn; Daniel Murray; Allan Klein; Robert G Humphries; Jonathan Turner; James David Thomas; Eric J Topol; A Michael Lincoff
Blockade of the platelet P2Y12 receptor by AR-C69931MX sustains coronary artery recanalization and improves the myocardial tissue perfusion in a canine thrombosis model.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(2):357-62.
2003: Deepak L Bhatt; Benjamin I Lee; Peter J Casterella; Mark Pulsipher; Matthew Rogers; Marc Cohen; Victor E Corrigan; Thomas J Ryan; Jeffrey A Breall; Jeffrey W Moses; Gregory M Eaton; Mitchel A Sklar; A Michael Lincoff
Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study.
Journal of the American College of Cardiology 2003;41(1):20-5.
2002: James C Blankenship; Craig Balog; Shelly K Sapp; Robert M Califf; A Michael Lincoff; James E Tcheng; Eric J Topol
Reduction in vascular access site bleeding in sequential abciximab coronary intervention trials.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2002;57(4):476-83.
2002: Debabrata Mukherjee; Hitinder S Gurm; W H Wilson Tang; Marco Roffi; Kathy Wolski; David J Moliterno; Victor Guetta; Diego Ardissinio; Christopher Bode; Gabriel Steg; A Michael Lincoff; Eric J Topol
Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab.
The American journal of cardiology 2002;90(11):1198-203.
2002: A Michael Lincoff; Robert M Califf; Frans Van de Werf; James T Willerson; Harvey D White; Paul W Armstrong; Victor Guetta; W Brian Gibler; Judith S Hochman; Christoph Bode; Alec Vahanian; Philippe Gabriel STEG; Diego Ardissino; Stefano Savonitto; Frits Bar; Zygmunt Sadowski; Amadeo Betriu; Joan E Booth; Kathy Wolski; Michael Waller; Eric J Topol
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial.
JAMA : the journal of the American Medical Association 2002;288(17):2130-5.
2002: M Ashequl Islam; James C Blankenship; Craig Balog; Elias A Iliadis; A Michael Lincoff; James E Tcheng; Robert M Califf; Eric J Topol
Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT).
The American journal of cardiology 2002;90(9):916-21.
2002: Zhongmin Zhou; Marc S Penn; Farhad Forudi; Xiaorong Zhou; Khaldoun Tarakji; Eric J Topol; A Michael Lincoff; Kai Wang
Administration of recombinant P-selectin glycoprotein ligand Fc fusion protein suppresses inflammation and neointimal formation in Zucker diabetic rat model.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(10):1598-603.
2002: Dean J Kereiakes; A Michael Lincoff; Keaven M Anderson; Robert Achenbach; Kamlesh Patel; Elliot Barnathan; Robert M Califf; Eric J Topol
Abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile.
The American journal of cardiology 2002;90(6):628-30.
2002: David R Holmes; Michael Savage; Jean-Marc LaBlanche; Lars Grip; P W Serruys; Peter Fitzgerald; David Fischman; Sheldon Goldberg; Jeffrey A Brinker; A M Zeiher; Leonard M Shapiro; James T Willerson; Barry R Davis; James J Ferguson; Jeffrey J Popma; Spencer B King; A Michael Lincoff; James E Tcheng; Robert Chan; Jeffrey R Granett; Marcia Poland
Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial.
Circulation 2002;106(10):1243-50.
2002: Kai Wang; Xiaorong Zhou; Zhongmin Zhou; Khaldoun Tarakji; Jian Xin Qin; Marta Sitges; Takahiro Shiota; Farhad Forudi; Robert G Schaub; Anjali Kumar; Marc S Penn; Eric J Topol; A Michael Lincoff
Recombinant soluble P-selectin glycoprotein ligand-Ig (rPSGL-Ig) attenuates infarct size and myeloperoxidase activity in a canine model of ischemia-reperfusion.
Thrombosis and haemostasis 2002;88(1):149-54.
2002: Arman T Askari; A Michael Lincoff
GUSTO V: combination drug treatment of acute myocardial infarction. Global Use of Strategies to Open Occluded Coronary Arteries.
Cleveland Clinic journal of medicine 2002;69(7):554-60.
2002: Eric J Topol; A Michael Lincoff; Dean J Kereiakes; Neal S Kleiman; Eric A Cohen; James J Ferguson; James E Tcheng; Shelly K Sapp; Robert M Califf
Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization.
The American journal of medicine 2002;113(1):1-6.
2002: Wei-Ching Chang; Robert A Harrington; Maarten L Simoons; Robert M Califf; A Michael Lincoff; Paul W Armstrong
Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT Trial.
European heart journal 2002;23(14):1102-11.
2002: Hitinder S Gurm; Danielle M Brennan; Joan Booth; James E Tcheng; A Michael Lincoff; Eric J Topol
Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox).
The American journal of cardiology 2002;90(1):42-5.
2002: Eli I Lev; Jonathan D Marmur; Milan Zdravkovic; Julio Osende; Jonathan Robbins; Jenny A Delfin; Merwin Richard; Elisabeth Erhardtsen; Mikael S Thomsen; A Michael Lincoff; Juan J Badimon
Antithrombotic effect of tissue factor inhibition by inactivated factor VIIa: an ex vivo human study.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(6):1036-41.
2002: Christopher K Dyke; Richard C Becker; Neal S Kleiman; Judith S Hochman; Edwin G Bovill; A Michael Lincoff; Gary Gerstenblith; Vladimir Dzavik; Laura H Gardner; Vic Hasselblad; Linda A Zillman; Yoshimasa Shimoto; Thomas L Robertson; Satoshi Kunitada; Paul W Armstrong; Robert A Harrington
First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation.
Circulation 2002;105(20):2385-91.
2002: Allen Jeremias; Deepak L Bhatt; Derek P Chew; Khaled M Ziada; Abdulhay Albirini; Sorin J Brener; A Michael Lincoff; Eric J Topol; Stephen G Ellis
Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency.
The American journal of cardiology 2002;89(10):1209-11.
2002: A Michael Lincoff; Neal S Kleiman; Kandice Kottke-Marchant; Elizabeth S Maierson; Kelly Maresh; Kathy Wolski; Eric J Topol
Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET).
American heart journal 2002;143(5):847-53.
2002: Stephen G Ellis; A Michael Lincoff; Patrick L Whitlow; Russell E Raymond; Irving Franco; Jakob P Schneider; Eric J Topol
Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stenting.
The American journal of cardiology 2002;89(8):937-40.
2002: James Ouzan; Catherine Pérault; A Michael Lincoff; Evelyne Carré; Michel Mertes
The role of spironolactone in the treatment of patients with refractory hypertension.
American journal of hypertension 2002;15(4 Pt 1):333-9.
2002: Jung Han Yoon; Chiung-Jen Wu; James Homme; Ronald J Tuch; Rodney G Wolff; Eric J Topol; A Michael Lincoff
Local delivery of nitric oxide from an eluting stent to inhibit neointimal thickening in a porcine coronary injury model.
Yonsei medical journal 2002;43(2):242-51.
2002: Wojciech Mazur; Grzegorz L Kaluza; Shelly Sapp; Craig Balog; Eric J Topol; Daniel B Mark; Stephen G Ellis; Dean J Kereiakes; A Michael Lincoff; Neal S Kleiman
Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists.
American heart journal 2002;143(4):594-601.
2002: Zhongmin Zhou; Michael A Lauer; Kai Wang; Farhad Forudi; Xiaorong Zhou; Xiao yu Song; Nancy Solowski; Samir R Kapadia; Marian T Nakada; Eric J Topol; A Michael Lincoff
Effect of anti-tumor necrosis factor-alpha polyclonal antibody on restenosis after balloon angioplasty in a rabbit atherosclerotic model.
Atherosclerosis 2002;161(1):153-9.
2002: K Martijn Akkerhuis; John H Alexander; Barbara E Tardiff; eric boersma; Robert A Harrington; A Michael Lincoff; Maarten L Simoons
Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?
Circulation 2002;105(5):554-6.
2002: A Michael Lincoff
The GUSTO-V clinical trial.
The Journal of invasive cardiology 2002;14 Suppl A():21A-30A.
2002: A Michael Lincoff
Management of acute coronary syndromes with emphasis on new information for the treatment of ST-segment elevation acute myocardial infarction.
The Journal of invasive cardiology 2002;14 Suppl A():1A-2A.
2002: Eelko Ronner; eric boersma; K Martijn Akkerhuis; Robert A Harrington; A Michael Lincoff; Jaap Deckers; K Karsch; N S Kleiman; A Vahanian; Eric J Topol; Robert M Califf; Maarten L Simoons
Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker.
European heart journal 2002;23(3):239-46.
2002: A Michael Lincoff
Targeting the use of platelet IIb/IIIa inhibitors: treatment of acute myocardial infarction.
Reviews in cardiovascular medicine 2002;3 Suppl 1():S13-9.
2001: M A Lauer; P L Houghtaling; JG Peterson; C B Granger; D L Bhatt; Shelly K Sapp; M L Simoons; Robert A Harrington; Eric J Topol; A Michael Lincoff
Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
Circulation 2001;104(23):2772-7.
2001: A Michael Lincoff
Anticoagulant and antiplatelet drugs.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2001;54(4):514-20.
2001: Stephen G Ellis; Sorin J Brener; A Michael Lincoff; David J Moliterno; Patrick L Whitlow; Jakob P Schneider; Eric J Topol
beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise.
Circulation 2001;104(22):2685-8.
2001: James E Tcheng; J D Talley; J Conor O'Shea; Ian C Gilchrist; Neal S Kleiman; Cindy L Grines; C J Davidson; A Michael Lincoff; Robert M Califf; L K Jennings; Michael M Kitt; Todd J Lorenz
Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study).
The American journal of cardiology 2001;88(10):1097-102.
2001: James E Tcheng; Dean J Kereiakes; A Michael Lincoff; Barry S George; Neal S Kleiman; David C Sane; Douglas B Cines; Robert E Jordan; Mary Ann Mascelli; Mary Ann Langrall; Lakshmi V Damaraju; A Schantz; Mark B Effron; Gregory A Braden
Abciximab readministration: results of the ReoPro Readministration Registry.
Circulation 2001;104(8):870-5.
2001: S H Park; Steven P Marso; Zhongmin Zhou; F Foroudi; Eric J Topol; A Michael Lincoff
Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus.
Circulation 2001;104(7):815-9.
2001: Kai Wang; Zhongmin Zhou; Xiaorong Zhou; Khaldoun Tarakji; Eric J Topol; A Michael Lincoff
Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model.
Journal of the American College of Cardiology 2001;38(2):577-82.
2001: B E Tardiff; L K Jennings; Robert A Harrington; D Gretler; R F Potthoff; D A Vorchheimer; P R Eisenberg; A Michael Lincoff; M Labinaz; D M Joseph; M F McDougal; Neal S Kleiman
Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUIT.
Circulation 2001;104(4):399-405.
2001: A Michael Lincoff; Dean J Kereiakes; Mary Ann Mascelli; L I Deckelbaum; Elliot S Barnathan; K K Patel; Bart Frederick; Marian T Nakada; Eric J Topol
Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization.
Circulation 2001;104(2):163-7.
2001: K Martijn Akkerhuis; Jaap Deckers; A Michael Lincoff; J E Tcheng; eric boersma; K Anderson; C Balog; Robert M Califf; Eric J Topol; Maarten L Simoons
Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention.
JAMA : the journal of the American Medical Association 2001;286(1):78-82.
2001: A Michael Lincoff
Combination therapy with reduced-dose fibrinolytic and platelet GP IIb/IIIa receptor inhibitors: SPEEDing into GUSTO V.
The Journal of invasive cardiology 2001;13 Suppl A():16A-18A.
2001: Herbert D Aronow; Eric J Topol; M T Roe; Penny L Houghtaling; Kathy Wolski; A Michael Lincoff; Robert A Harrington; Robert M Califf; Erik Ohman; Neal S Kleiman; Mátyás Keltai; Robert G Wilcox; Alec Vahanian; Paul W Armstrong; Michael Lauer
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study.
Lancet 2001;357(9262):1063-8.
2001: JG Peterson; Eric J Topol; M T Roe; Shelly K Sapp; A Michael Lincoff; J W Deckers; Eugene Blackstone; Robert A Harrington; Robert M Califf; Michael Lauer
Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.
The American journal of cardiology 2001;87(5):532-6.
2001: Derek P Chew; Deepak L Bhatt; A Michael Lincoff; David J Moliterno; Sorin J Brener; Kathy Wolski; Eric J Topol
Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials.
Circulation 2001;103(7):961-6.
2001: Adam B Greenbaum; Robert A Harrington; Michael P Hudson; C M MacAulay; Robert G Wilcox; Maarten L Simoons; Lisa G Berdan; AD Guerci; D V Cokkinos; Michael M Kitt; A Michael Lincoff; Eric J Topol; Robert M Califf; Erik Ohman
Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators.
Journal of the American College of Cardiology 2001;37(2):492-8.
2000: A Michael Lincoff; D B Mark; James E Tcheng; Robert M Califf; M V Bala; KM Anderson; L Davidson-Ray; J D Knight; CF Cabot; Eric J Topol
Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade.
Circulation 2000;102(24):2923-9.
2000: A Michael Lincoff
GUSTO IV: expanding therapeutic options in acute coronary syndromes.
American heart journal 2000;140(6 Suppl):S103-14.
2000: Howard C Herrmann; David J Moliterno; Erik Ohman; Amanda L Stebbins; C Bode; A Betriu; F Forycki; J S Miklin; W B Bachinsky; A Michael Lincoff; Robert M Califf; Eric J Topol
Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial.
Journal of the American College of Cardiology 2000;36(5):1489-96.
2000: JG Peterson; Eric J Topol; Shelly K Sapp; J B Young; A Michael Lincoff; Michael Lauer
Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease.
The American journal of medicine 2000;109(5):371-7.
2000: M T Roe; Robert A Harrington; D M Prosper; Karen S Pieper; D L Bhatt; A Michael Lincoff; Maarten L Simoons; M Akkerhuis; Erik Ohman; Michael M Kitt; A Vahanian; W Ruzyllo; K Karsch; Robert M Califf; Eric J Topol
Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators.
Circulation 2000;102(10):1101-6.
2000: A Michael Lincoff; Robert A Harrington; Robert M Califf; Judith S Hochman; AD Guerci; Erik Ohman; Carl J Pepine; S L Kopecky; Neal S Kleiman; Cindy M Pacchiana; Lisa G Berdan; Michael M Kitt; Maarten L Simoons; Eric J Topol
Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
Circulation 2000;102(10):1093-100.
2000: A Michael Lincoff; L A LeNarz; G J Despotis; P K Smith; Joan E Booth; R E Raymond; Shelly K Sapp; CF Cabot; James E Tcheng; Robert M Califf; M B Effron; Eric J Topol
Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing.
The Annals of thoracic surgery 2000;70(2):516-26.
2000: Leslie Cho; Eric J Topol; Craig Balog; JoAnne M Foody; Joan E Booth; CF Cabot; Neal S Kleiman; James E Tcheng; Robert M Califf; A Michael Lincoff
Clinical benefit of glycoprotein IIb/IIIa blockade with Abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation in Percutaneous Transluminal Coronary Angioplasty to Improve Long-Term Outcome with Abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stent.
Journal of the American College of Cardiology 2000;36(2):381-6.
2000: Fernando A Cura; Deepak L Bhatt; A Michael Lincoff; Samir R Kapadia; Philippe L L'Allier; Khaled M Ziada; Kathy Wolski; David J Moliterno; Sorin J Brener; Stephen G Ellis; Eric J Topol
Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions.
Circulation 2000;102(1):28-34.
2000: Dean J Kereiakes; Scott Darrell Berkowitz; A Michael Lincoff; James E Tcheng; K Wolski; R Achenbach; R Melsheimer; K Anderson; Robert M Califf; Eric J Topol
Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade.
American heart journal 2000;140(1):74-80.
2000: eric boersma; K S Pieper; E W Steyerberg; Robert G Wilcox; W C Chang; K L Lee; K Martijn Akkerhuis; Robert A Harrington; Jaap Deckers; Paul W Armstrong; A Michael Lincoff; Robert M Califf; Eric J Topol; Maarten L Simoons
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.
Circulation 2000;101(22):2557-67.
2000: Deepak L Bhatt; A Michael Lincoff; Robert M Califf; Maarten L Simoons; James E Tcheng; Sorin J Brener; Kathy Wolski; Eric J Topol
The benefit of abciximab in percutaneous coronary revascularization is not device-specific.
The American journal of cardiology 2000;85(9):1060-4.
2000: KR Campbell; Erik Ohman; Warren J Cantor; A Michael Lincoff
The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends.
The American journal of cardiology 2000;85(8A):32C-8C.
2000: A Michael Lincoff; Robert M Califf; Eric J Topol
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.
Journal of the American College of Cardiology 2000;35(5):1103-15.
2000: Deepak L Bhatt; Steven P Marso; A Michael Lincoff; Kathy Wolski; Stephen G Ellis; Eric J Topol
Abciximab reduces mortality in diabetics following percutaneous coronary intervention.
Journal of the American College of Cardiology 2000;35(4):922-8.
2000: K Martijn Akkerhuis; Jaap Deckers; eric boersma; Robert A Harrington; J Stepinska; Kenneth W Mahaffey; Robert G Wilcox; A Michael Lincoff; Mátyás Keltai; Eric J Topol; Robert M Califf; Maarten L Simoons
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT.
European heart journal 2000;21(5):371-81.
2000: Neal S Kleiman; A Michael Lincoff; G C Flaker; Karen S Pieper; Robert G Wilcox; Lisa G Berdan; Todd J Lorenz; D V Cokkinos; Maarten L Simoons; E Boersma; Eric J Topol; Robert M Califf; Robert A Harrington
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators.
Circulation 2000;101(7):751-7.
2000: M C Thel; Robert M Califf; Barbara E Tardiff; Laura H Gardner; Kristina N Sigmon; A Michael Lincoff; Eric J Topol; Michael M Kitt; James C Blankenship; James E Tcheng
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.
The American journal of cardiology 2000;85(4):427-34.
2000: Daniel B Mark; Robert A Harrington; A Michael Lincoff; Robert M Califf; Charlotte L Nelson; Anastasios A Tsiatis; Hope E Buell; Kenneth W Mahaffey; Linda Davidson-Ray; Eric J Topol
Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes.
Circulation 2000;101(4):366-71.
2000: A Michael Lincoff
Potent complementary clinical benefit of abciximab and stenting during percutaneous coronary revascularization in patients with diabetes mellitus: results of the EPISTENT trial.
American heart journal 2000;139(2 Pt 2):S46-52.
2000: D Holmes; P Fitzgerald; S Goldberg; Jean-Marc LaBlanche; A Michael Lincoff; M Savage; P W Serruys; James T Willerson; Jeffrey R Granett; R Chan; N H Shusterman; M Poland
The PRESTO (Prevention of restenosis with tranilast and its outcomes) protocol: a double-blind, placebo-controlled trial.
American heart journal 2000;139(1 Pt 1):23-31.
1999: Steven P Marso; A Michael Lincoff; Stephen G Ellis; Deepak L Bhatt; Jean-François Tanguay; Neal S Kleiman; Talal Hammoud; Joan E Booth; Shelly K Sapp; Eric J Topol
Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy.
Circulation 1999;100(25):2477-84.
1999: Eric J Topol; D B Mark; A Michael Lincoff; E Cohen; J Burton; Neal S Kleiman; D Talley; Shelly K Sapp; J Booth; CF Cabot; KM Anderson; Robert M Califf
Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting.
Lancet 1999;354(9195):2019-24.
1999: Mark A Robbins; Steven P Marso; Kathy Wolski; J Peterson; A Michael Lincoff; Sorin J Brener
Chest pain--a strong predictor of adverse cardiac events following precutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISENT])].
The American journal of cardiology 1999;84(11):1350-3, A8.
1999: I C Gilchrist; Laura H Gardner; J B Muhlestein; A M Arnold; A Michael Lincoff; Robert M Califf; James E Tcheng; Eric J Topol
Effect of institutional volume and academic status on outcomes of coronary interventions: the IMPACT-II experience.
American heart journal 1999;138(5 Pt 1):976-82.
1999: A Michael Lincoff; Robert M Califf; David J Moliterno; Stephen G Ellis; J Ducas; J H Kramer; Neal S Kleiman; Eric A Cohen; Joan E Booth; Shelly K Sapp; CF Cabot; Eric J Topol
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
The New England journal of medicine 1999;341(5):319-27.
1999: M W McClure; Scott Darrell Berkowitz; rodney sparapani; R Tuttle; Neal S Kleiman; Lisa G Berdan; A Michael Lincoff; Jaap Deckers; R Diaz; K R Karsch; D Gretler; Michael M Kitt; Maarten L Simoons; Eric J Topol; Robert M Califf; Robert A Harrington
Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience.
Circulation 1999;99(22):2892-900.
1999: Kenneth W Mahaffey; Robert A Harrington; Maarten L Simoons; Christopher B Granger; Carmelo Graffagnino; Mark J Alberts; Daniel T Laskowitz; Julie M Miller; Michael A Sloan; Lisa G Berdan; C M MacAulay; A Michael Lincoff; Jaap Deckers; Eric J Topol; Robert M Califf
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators.
Circulation 1999;99(18):2371-7.
1999: A Michael Lincoff; James E Tcheng; Robert M Califf; Dean J Kereiakes; T A Kelly; G C Timmis; Neal S Kleiman; Joan E Booth; Craig Balog; CF Cabot; KM Anderson; HF Weisman; Eric J Topol
Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade.
Circulation 1999;99(15):1951-8.
1999: John H Alexander; Robert A Harrington; Robert H Tuttle; Lisa G Berdan; A Michael Lincoff; Jaap Deckers; Maarten L Simoons; AD Guerci; Judith S Hochman; Robert G Wilcox; Michael M Kitt; P R Eisenberg; Robert M Califf; Eric J Topol; K Karsh; W Ruzyllo; J Stepinska; P Widimsky; J B Boland; Paul W Armstrong
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy.
The American journal of cardiology 1999;83(8):1147-51.
1999: Stephen G Ellis; D Miller; Thomas F Keys; K Brown; R Ellert; G Howell; A Michael Lincoff; Eric J Topol
Comparing physician-specific two-year patient outcomes after coronary angiography: methodologic issues and results.
Journal of the American College of Cardiology 1999;33(5):1278-85.
1999: J W Smith; Steven R Steinhubl; A Michael Lincoff; J C Coleman; T T Lee; R S Hillman; Barry S Coller
Rapid platelet-function assay: an automated and quantitative cartridge-based method.
Circulation 1999;99(5):620-5.
1999: M C Thel; Robert M Califf; James E Tcheng; Kristina N Sigmon; A Michael Lincoff; Eric J Topol; Stephen G Ellis
Clinical risk factors for ischemic complications after percutaneous coronary interventions: results from the EPIC trial. The EPIC Investigators.
American heart journal 1999;137(2):264-73.
1999: Robert A Harrington; Robert M Califf; D R Holmes; Karen S Pieper; A Michael Lincoff; Lisa G Berdan; T D Thompson; Eric J Topol
Is all unstable angina the same? insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I). The CAVEAT-Investigators.
American heart journal 1999;137(2):227-33.
1999: Barbara E Tardiff; Robert M Califf; James E Tcheng; A Michael Lincoff; Kristina N Sigmon; Robert A Harrington; Kenneth W Mahaffey; Erik Ohman; P S Teirstein; James C Blankenship; Michael M Kitt; Eric J Topol
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II.
Journal of the American College of Cardiology 1999;33(1):88-96.
1998: David F Kong; Robert M Califf; D P Miller; David J Moliterno; Harvey D White; Robert A Harrington; James E Tcheng; A Michael Lincoff; Vic Hasselblad; Eric J Topol
Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease.
Circulation 1998;98(25):2829-35.
1998: Stephen G Ellis; A Michael Lincoff; D Miller; James E Tcheng; Neal S Kleiman; Dean J Kereiakes; Robert M Califf; Eric J Topol
Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Blockade.
Journal of the American College of Cardiology 1998;32(6):1619-23.
1998: Deepak L Bhatt; A Michael Lincoff; Dean J Kereiakes; James E Tcheng; Maarten L Simoons; L R van der Wieken; N Godfrey; Robert M Califf; Eric J Topol
Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention.
The American journal of cardiology 1998;82(9):1105-6, A6.
1998: Steven R Steinhubl; Michael Lauer; Debabrata Mukherjee; David J Moliterno; A Michael Lincoff; Stephen G Ellis; Eric J Topol
The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non-Q-wave myocardial infarctions.
Journal of the American College of Cardiology 1998;32(5):1366-70.
1998: A Michael Lincoff
Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization.
The American journal of cardiology 1998;82(8B):36P-42P.
1998: Neal S Kleiman; A Michael Lincoff; Erik Ohman; Robert A Harrington
Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: pathophysiologic foundation and clinical findings.
American heart journal 1998;136(4 Pt 2 Su):S32-42.
1998: Sasan Ghaffari; Dean J Kereiakes; A Michael Lincoff; T A Kelly; G C Timmis; Neal S Kleiman; James J Ferguson; DP Miller; Robert M Califf; Eric J Topol
Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy. EPILOG Investigators. Evaluation of PTCA to Improve Long-term Outcome by c7E3 GP IIb/IIIa Receptor Blockade.
The American journal of cardiology 1998;82(1):7-12.
1998: J S Mandak; James C Blankenship; Laura H Gardner; Scott Darrell Berkowitz; FV Aguirre; Kristina N Sigmon; G C Timmis; I C Gilchrist; Michael E. McIvor; Jon R Resar; B H Weiner; BS George; J D Talley; A Michael Lincoff; James E Tcheng; Robert M Califf; Eric J Topol
Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.
Journal of the American College of Cardiology 1998;31(7):1518-24.
1998: Neal S Kleiman; A Michael Lincoff; Dean J Kereiakes; DP Miller; FV Aguirre; KM Anderson; HF Weisman; Robert M Califf; Eric J Topol
Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators.
Circulation 1998;97(19):1912-20.
1998: Dean J Kereiakes; A Michael Lincoff; DP Miller; James E Tcheng; CF Cabot; KM Anderson; HF Weisman; Robert M Califf; Eric J Topol
Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators.
Circulation 1998;97(9):857-64.
1997: Steven R Steinhubl; A Michael Lincoff
Antithrombotic therapy with intracoronary stenting.
Heart (British Cardiac Society) 1997;78 Suppl 2():21-3.
1997: A Michael Lincoff; Robert M Califf; KM Anderson; HF Weisman; FV Aguirre; Neal S Kleiman; Robert A Harrington; Eric J Topol
Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. EPIC Investigators. Evaluation of 7E3 in Preventing Ischemic Complications.
Journal of the American College of Cardiology 1997;30(1):149-56.
1997: A Michael Lincoff; J G Furst; Stephen G Ellis; R J Tuch; Eric J Topol
Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model.
Journal of the American College of Cardiology 1997;29(4):808-16.
1997: M Gottsauner-Wolf; Y Jang; A Michael Lincoff; J L Cohen; V Labhasetwar; Earl Poptic; Farhad Forudi; L A Guzman; Paul E DiCorleto; R J Levy; Eric J Topol; Stephen G Ellis
Influence of local delivery of the protein tyrosine kinase receptor inhibitor tyrphostin-47 on smooth-muscle cell proliferation in a rat carotid balloon-injury model.
American heart journal 1997;133(3):329-34.
1997: A Michael Lincoff; James E Tcheng; Robert M Califf; T Bass; J J Popma; P S Teirstein; Neal S Kleiman; L J Hattel; H V Anderson; James J Ferguson; CF Cabot; KM Anderson; Lisa G Berdan; M H Musco; HF Weisman; Eric J Topol
Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators.
The American journal of cardiology 1997;79(3):286-91.
1996: Steven P Schulman; Pascal J Goldschmidt-Clermont; Eric J Topol; Robert M Califf; F I Navetta; J T Willerson; NISHA CHANDRA; A D Guerci; J J Ferguson; Robert A Harrington; A Michael Lincoff; S J Yakubov; Paul F Bray; R D Bahr; C L Wolfe; P G Yock; H V Anderson; T W Nygaard; S J Mason; M B Effron; A Fatterpacker; S Raskin; J Smith; L Brashears; P Gottdiener; C du Mee; Michael M Kitt; Gary Gerstenblith
Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial.
Circulation 1996;94(9):2083-9.
1996: L A Guzman; V Labhasetwar; C Song; Y Jang; A Michael Lincoff; R Levy; Eric J Topol
Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty.
Circulation 1996;94(6):1441-8.
1996: M Gottsauner-Wolf; David J Moliterno; A Michael Lincoff; Eric J Topol
Restenosis--an open file.
Clinical cardiology 1996;19(5):347-56.
1995: Robert A Harrington; Neal S Kleiman; Kandice Kottke-Marchant; A Michael Lincoff; James E Tcheng; Kristina N Sigmon; D Joseph; G Rios; K Trainor; D Rose
Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention.
The American journal of cardiology 1995;76(17):1222-7.
1995: Y Jang; L A Guzman; A Michael Lincoff; M Gottsauner-Wolf; F Forudi; CE Hart; D W Courtman; M Ezban; Stephen G Ellis; Eric J Topol
Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model.
Circulation 1995;92(10):3041-50.
1995: Erik Ohman; Robert A Harrington; A Michael Lincoff; Michael M Kitt; Neal S Kleiman; James E Tcheng
Early clinical experience with integrelin, an inhibitor of the platelet glycoprotein IIb/IIIa integrin receptor.
European heart journal 1995;16 Suppl L():50-5.
1995: Robert M Califf; A Michael Lincoff; James E Tcheng; Eric J Topol
An overview of the results of the EPIC trial.
European heart journal 1995;16 Suppl L():43-9.
1995: Robert A Harrington; A Michael Lincoff; Robert M Califf; David R Holmes; Lisa G Berdan; M A O'Hanesian; Gordon Keeler; K N Garratt; Erik Ohman; D B Mark
Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT).
Journal of the American College of Cardiology 1995;25(7):1693-9.
1995: A Michael Lincoff; Eric J Topol; Robert M Califf; Kristina N Sigmon; K L Lee; Erik Ohman; U Rosenschein; Stephen G Ellis
Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
The American journal of cardiology 1995;75(14):871-6.
1995: Stephen G Ellis; MJ Cowley; Patrick L Whitlow; M Vandormael; A Michael Lincoff; G DiSciascio; L S Dean; Eric J Topol
Prospective case-control comparison of percutaneous transluminal coronary revascularization in patients with multivessel disease treated in 1986-1987 versus 1991: improved in-hospital and 12-month results. Multivessel Angioplasty Prognosis Study (MAPS) Group.
Journal of the American College of Cardiology 1995;25(5):1137-42.
1994: Y Jang; A Michael Lincoff; E F Plow; Eric J Topol
Cell adhesion molecules in coronary artery disease.
Journal of the American College of Cardiology 1994;24(7):1591-601.
1994: A Michael Lincoff; Eric J Topol; Stephen G Ellis
Local drug delivery for the prevention of restenosis. Fact, fancy, and future.
Circulation 1994;90(4):2070-84.
1994: A Michael Lincoff
Patients at high risk for ischemic complications.
The Journal of invasive cardiology 1994;6 Suppl A():13A-18A; discussion 50A-51A.
1993: A Michael Lincoff; Robert M Califf; Stephen G Ellis; Kristina N Sigmon; K L Lee; J D Leimberger; Eric J Topol
Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
Journal of the American College of Cardiology 1993;22(7):1780-7.
1993: A Michael Lincoff; Eric J Topol
Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?
Circulation 1993;88(3):1361-74.
1993: A Michael Lincoff; Eric J Topol; A T Chapekis; B S George; R J Candela; David W Muller; C A Zimmerman; Stephen G Ellis
Intracoronary stenting compared with conventional therapy for abrupt vessel closure complicating coronary angioplasty: a matched case-control study.
Journal of the American College of Cardiology 1993;21(4):866-75.